Skip to Content
  • Title
    Director
  • Affiliation
    Wellcome Trust

In 2003, when bird flu reemerged in humans, studies at a key lab in Vietnam—run by a British clinician—gave the world deep insights into the virus. When that same physician, Jeremy Farrar, became head of the Wellcome Trust and its $26 billion endowment two years ago, infectious-disease research got a new global champion. Under Farrar, Wellcome has not only doubled down on Ebola research but also fast-tracked clinical trials of potential treatments.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access